Study Information

Title: A Safety Study of SGN-CD19A for Leukemia and Lymphoma External
Status: Recruiting participants
Conditions: Burkitt Lymphoma; Precursor B-cell Lymphoblastic Leukemia-Lymphoma
Interventions: Drug: SGN-CD19A
Institutions: Children's Hospital Boston, Dana-Farber Cancer Institute, Massachusetts General Hospital
Health Topics: Acute Lymphocytic Leukemia (ALL) in Adults, Acute Lymphocytic Leukemia (ALL) in Children, Non-Hodgkin Lymphoma

Contact Information


Boston Children's Hospital
Boston, MA 02215
Lindsay Williams
617-582-9709
LindsayS_Williams@dfci.harvard.edu
Dana Farber Cancer Institute
Boston, MA 02215
Stacie-Ann Sammott
617-582-8287
Stacie-AnnS_Sammott@DFCI.HARVARD.EDU
Massachusetts General Hospital
Boston, MA 02114
Meghan Burke
617-643-5126
MBURKE19@PARTNERS.ORG